Trials / Completed
CompletedNCT00488241
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
A Multicenter, Open Uncontrolled Clinical Study to Examine the Efficacy and Safety of Zarzenda in the Management of Hand Eczema
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To show efficacy of Zarzenda in the treatment of hand eczema
Detailed description
The objective of the study is to demonstrate efficacy and safety of Zarzenda (a medical device) in the management of hand eczema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zarzenda | Topically applied daily for 2 weeks |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-09-01
- Completion
- 2007-09-01
- First posted
- 2007-06-20
- Last updated
- 2023-10-31
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00488241. Inclusion in this directory is not an endorsement.